Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Bourlon

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Practical Radiation Oncology|July 5, 2015
Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?Arya Amini, Basel Altoos, Maria T Bourlon, et al.
Clinical Drug Investigation|June 13, 2022
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell CarcinomaDaniel M Geynisman, Mauricio Burotto, Camillo Porta, et al.
The Oncologist|September 20, 2022
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
JCO Global Oncology|January 25, 2024
Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial CarcinomaRay Manneh Kopp, Fernando Galanternik, Fabio A Schutz, et al.
Critical Reviews in Oncology/Hematology|March 9, 2024
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysisFernando Sabino Marques Monteiro, Andrey Soares, Veronica Mollica, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2020
Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic PopulationChristianne Bourlon, Rocío Camacho-Hernández, Oscar M Fierro-Angulo, et al.
BMC Cancer|September 15, 2020
Immunosenescence profile and expression of the aging biomarker (p16<sup>INK4a</sup>) in testicular cancer survivors treated with chemotherapyMaria T Bourlon, Hugo E Velazquez, Juan Hinojosa, et al.
JCO Global Oncology|April 11, 2024
Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCOMaria T Bourlon, Ami S Bhatt, Gilberto Lopes, et al.
Frontiers in Oncology|January 3, 2024
Overview and characterization of penile cancer content across social media platformsRuben Alejandro Ortiz-Guerra, Salvador Jaime-Casas, Bertha Alejandra Martinez-Cannon, et al.
JCO Global Oncology|November 5, 2020
Recommendations from the ASCO Academic Global Oncology Task ForceJulie R Gralow, Fredrick Chite Asirwa, Ami Siddharth Bhatt, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Practical Radiation Oncology|July 5, 2015
Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?Arya Amini, Basel Altoos, Maria T Bourlon, et al.
Clinical Drug Investigation|June 13, 2022
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell CarcinomaDaniel M Geynisman, Mauricio Burotto, Camillo Porta, et al.
The Oncologist|September 20, 2022
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
JCO Global Oncology|January 25, 2024
Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial CarcinomaRay Manneh Kopp, Fernando Galanternik, Fabio A Schutz, et al.
Critical Reviews in Oncology/Hematology|March 9, 2024
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysisFernando Sabino Marques Monteiro, Andrey Soares, Veronica Mollica, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2020
Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic PopulationChristianne Bourlon, Rocío Camacho-Hernández, Oscar M Fierro-Angulo, et al.
BMC Cancer|September 15, 2020
Immunosenescence profile and expression of the aging biomarker (p16<sup>INK4a</sup>) in testicular cancer survivors treated with chemotherapyMaria T Bourlon, Hugo E Velazquez, Juan Hinojosa, et al.
JCO Global Oncology|April 11, 2024
Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCOMaria T Bourlon, Ami S Bhatt, Gilberto Lopes, et al.
Frontiers in Oncology|January 3, 2024
Overview and characterization of penile cancer content across social media platformsRuben Alejandro Ortiz-Guerra, Salvador Jaime-Casas, Bertha Alejandra Martinez-Cannon, et al.
JCO Global Oncology|November 5, 2020
Recommendations from the ASCO Academic Global Oncology Task ForceJulie R Gralow, Fredrick Chite Asirwa, Ami Siddharth Bhatt, et al.
Pageof 8